secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001493152-26-009799
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health FY2025 net loss down 76%; Population Health revenue up 157% to $5.3M
--------------------------------------------------------------------------------

- FY2025 revenue $7.2M (-9% YoY); net loss improved 76% to ($896K) from ($3.8M).
- EPS improved to ($0.08) from ($0.50) in FY2024; Q4 2025 net loss ($135K) vs ($504K) Q4 2024.
- Population Health revenue grew 157% to $5.3M; gross margin expanded to 34.4% from 20.7%.
- Operating expenses down 37% to $3.4M; adjusted EBITDA improved to ($863K) from ($3.7M).
- Company expects profitability by year-end 2026; cash $1.6M, no long-term debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226009799/0001493152-26-009799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226009799/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer